Smallpox
📧 Sign up to get email alerts when something new happens for Smallpox.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-01-29Clinical Trial Update: Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of BSY001 After Single/Multiple Doses. [Phase 1]
Early-phase Phase 1 trial to evaluate the safety, tolerability, and pharmacokinetics of BSY001 after single and multiple doses; currently re…
-
CLINICAL_TRIALS research · 2025-11-24Clinical Trial Update: Open-label, Multicenter Immunogenicity and Safety Study of MVA-BN Vaccine in Children From 2 Years to Less Than 12 Years of Age Compared to Adults for the Prevention of Smallpox, Mpox, and Related Orthopoxvirus Infections [Phase 2]
An open-label Phase 2 multicenter immunogenicity and safety study evaluating the MVA-BN vaccine in children aged 2 to under 12 years, compar…
-
CLINICAL_TRIALS research · 2025-10-16Clinical Trial Update: Evaluating the Human Immune Response to the JYNNEOS Vaccine [EARLY_Phase 1]
Early-phase trial evaluating the human immune response to the JYNNEOS vaccine. The study status is Active Not Recruiting.
-
CLINICAL_TRIALS research · 2015-04-07Clinical Trial Update: VHA Clinicians and Bioterror Events: Interactive Web-based Learning [NA]
Completed clinical trial evaluating an interactive web-based learning module for VA clinicians on bioterror events related to smallpox and a…
-
CLINICAL_TRIALS research · 2014-01-22Clinical Trial Update: Safety Study of MVA Smallpox Vaccine in HIV-positive Subjects Who Are Vaccinia Naive [Phase 1]
Phase 1 safety study of the Modified Vaccinia Ankara (MVA) smallpox vaccine in HIV-positive, vaccinia-naive individuals; the trial sponsored…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2007-01-15Clinical Trial Update: Safety and Immunogenicity Study of LC16m8, a Modified Smallpox Vaccine, in Healthy, Previously Unvaccinated Volunteers [Phase 1, Phase 2]
This document provides an update on a Phase 1/2 safety and immunogenicity study of LC16m8, a modified smallpox vaccine, in healthy volunteer…